Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study

Once-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) may increase patient adherence to treatment but may also be associated with a higher risk of bleeding. In this study, we investigated the adherence to once- or twice-daily dosing of NOACs and the risk of bleeding in nonvalvula...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bosn J Basic Med Sci
Autores principales: Emren, Sadık Volkan, Zoghi, Mehdi, Berilgen, Rida, Özdemir, İbrahim Halil, Çelik, Oğuzhan, Çetin, Nurullah, Enhoş, Asım, Köseoğlu, Cemal, Akyüz, Abdurrahman, Doğan, Volkan, Levent, Fatih, Dereli, Yüksel, Doğan, Tolga, Başaran, Özcan, Karaca, Ilgın, Karaca, Özkan, Otlu, Yılmaz Ömür, Özmen, Çağlar, Coşar, Selvi, Sümerkan, Mutlu, Gürsul, Erdal, İnci, Sinan, Onrat, Ersel, Ergene, Oktay
Formato: Artigo
Lenguaje:Inglês
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2018
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5988538/
https://ncbi.nlm.nih.gov/pubmed/28968197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17305/bjbms.2017.2279
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares